Rachel King, CEO of Glycomimetics, on H.R. 3
Rachel King, CEO of Glycomimetics, Inc. in Rockville, MD discusses the dangers of importing foreign reference pricing and the role that biotechnology companies want to play in improving the lives of patients with debilitating diseases.